Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
Industrial Promotion and Investment Corporation of Odisha and the industry body Federation of Indian Chambers of Commerce and Industry (FICCI) have signed an MoU making the latter a national industry partner for the Make in Odisha Conclave 2022.